UiPath Stock And 2 Founder Led Software Companies Worth Watching

Founder led stocks can offer something many investors value in a world of mixed inflation signals, cautious central banks and shifting trade policies: leaders whose personal legacy is tied closely to long term performance. With services and manufacturing activity stabilizing in key regions and energy and tariff risks still in focus, committing capital alongside founders can be one way to stay grounded in business fundamentals rather than short term headlines. This article highlights 3 of the best opportunities from the Founder Led Companies screener, helping you focus on management quality and long term alignment as you build your watchlist.

UiPath (PATH)

Overview: UiPath is an automation software company that helps businesses use AI agents and software robots to handle repetitive tasks across finance, healthcare, manufacturing, retail and government, so employees can focus on higher value work. Its platform coordinates people, robots and AI models in a single workflow system to manage everything from document processing to software testing.

Operations: UiPath generates about US$1.7b in revenue primarily from Software & Programming, with around US$739m from the United States and the rest mainly from Europe, the Middle East and Africa plus other Americas regions.

Market Cap: US$5.3b

UiPath stands out for investors who want founder influence, exposure to AI driven automation and a business that has recently moved into profitability while trading well below Simply Wall St’s estimate of fair value. The company is leaning into agentic AI, with products such as Agent Builder and Maestro process orchestration, and partnerships with groups such as Deloitte, Microsoft and Databricks. These aim to deepen customer usage and support cloud annual recurring revenue already above US$975m. At the same time, revenue growth expectations are modest, foreign exchange and a shift to a SaaS model are weighing on near term figures, and analysts highlight softer guidance as a risk. Investors therefore need to weigh a seemingly attractive P/E and optimistic analyst targets against these execution and macro headwinds.

UiPath’s shift into profitability and a seemingly low P/E create a story that feels incomplete without seeing how the market is pricing those AI ambitions and execution risks side by side, so review the DCF valuation analysis for UiPath.

Hinge Health (HNGE)

Overview: Hinge Health is a healthcare technology company that provides digital musculoskeletal care, combining app based physical therapy, AI powered motion tracking and a nerve stimulation wearable to help people manage injuries, chronic pain and post surgery recovery. It mainly works with large self insured employers and health plans that offer the program as a benefit to their members.

Operations: Hinge Health generates about US$646.3m in revenue from Healthcare Software.

Market Cap: US$6.1b

Hinge Health gives you exposure to tech enabled care at scale, with its musculoskeletal platform already covering around 24.6 million contracted lives, millions of member sessions and a large data set that feeds AI tools such as the Robin assistant. That scale is helping support revenue growth and improving margins. However, the company is still loss making, carries higher risk funding and trades on a rich P/S multiple, so the bar for future execution is high. For investors willing to accept that trade off, the raised guidance, new programs like HingeSelect and migraine care, and positive analyst expectations on earnings and fair value make Hinge Health a business some investors may want to research more closely.

Hinge Health’s rapid scale in digital musculoskeletal care, rich data set, and new programs like HingeSelect put growth and margins in a tight race, so check how analysts are framing that trade off in the analyst forecasts for Hinge Health

Pegasystems (PEGA)

Overview: Pegasystems is an enterprise software company that helps large organisations automate workflows and customer service using its Pega Infinity platform, combining AI powered decisioning, case management and customer engagement tools. Its software is used across industries such as financial services, healthcare, telecoms, government and manufacturing to streamline complex processes and improve customer interactions.

Operations: Pegasystems generates about US$1.7b in revenue from Software & Programming, with around US$894.5m from the United States and the rest from Asia Pacific, other Americas, the United Kingdom and wider Europe, the Middle East and Africa.

Market Cap: US$4.3b

Pegasystems may appeal to founder focused investors because it combines long standing leadership with an AI centric product set and a business model built around recurring software income. The company is focusing on Pega Cloud and tools like Pega GenAI Blueprint and Infinity 26 to help clients manage AI costs and modernise legacy systems. In addition, buybacks, cash generation and past earnings growth are relevant for assessing capital use. At the same time, slower forecast earnings growth, customer caution on AI projects and recent analyst downgrades after softer ACV trends indicate that execution risk is a consideration. For investors, the interest lies in how this mix of AI workflow demand, cloud adoption and funding structure could develop from here.

Pegasystems’ AI workflow capabilities and recurring software base seem to represent only half the picture. The real question is how the market is weighing those strengths against execution risk in the analysis report for Pegasystems.

The three founder led stocks in this article are only a starting point. The full screener flags 1,455 more companies with leaders whose stories and incentives may be just as compelling as the ones you have seen so far in the Founder-Led Companies screener. Use Simply Wall St to identify, filter and analyze the exact catalysts and founder narratives that matter to you so you can focus on the highest conviction opportunities aligned with your own checklist.

Take Control of Your Investment Journey

If Hinge Health or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Fresh ideas move fast, and the best setups rarely stay under the radar for long. Spot potential breakouts and shifting momentum while it matters, then get in early.

• Spot resilient income plays that aim to keep paying through cycles by scanning a curated pool of 7 dividend fortresses before yields get compressed by late arrivals.
• Catch early movers in AI infrastructure as capital flows toward the picks and shovels of computing by using a focused set of 54 AI infrastructure stocks before momentum crowds in.
• Target companies building the rails for tomorrow’s robotics economy by zeroing in on carefully filtered 34 robotics and automation stocks while many investors are still looking elsewhere.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com